GuardionHealthSciences (002).jpg
Guardion Health Sciences Announces Corporate Milestones Designed to Strengthen Financial Results and Improve Customer and Investor Engagement
October 14, 2021 08:00 ET | Guardion Health Sciences, Inc.
HOUSTON, Oct. 14, 2021 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a clinical nutrition and diagnostics company that develops and markets...
GuardionHealthSciences (002).jpg
Guardion Health Sciences Stockholders Urged to Vote Their Shares for October 22, 2021 Annual Meeting
October 12, 2021 10:30 ET | Guardion Health Sciences, Inc.
HOUSTON, Oct. 12, 2021 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a clinical nutrition and diagnostics company that develops clinically...
GuardionHealthSciences (002).jpg
Guardion Health Sciences to Present at the LD Micro Main Event Conference
October 05, 2021 08:00 ET | Guardion Health Sciences, Inc.
HOUSTON, Oct. 05, 2021 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a clinical nutrition and diagnostics company that develops clinically...
GuardionHealthSciences (002).jpg
Guardion Health Sciences to Present at the Benzinga Healthcare Small Cap Conference
September 27, 2021 09:15 ET | Guardion Health Sciences, Inc.
HOUSTON, Sept. 27, 2021 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a clinical nutrition and diagnostics company that develops clinically...
GuardionHealthSciences (002).jpg
Guardion Health Sciences to Present at the H.C. Wainwright 23rd Annual Global Investment Virtual Conference
September 09, 2021 08:30 ET | Guardion Health Sciences, Inc.
SAN DIEGO, Sept. 09, 2021 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a clinical nutrition and diagnostics company that develops clinically...
GuardionHealthSciences (002).jpg
Guardion Health Sciences Announces Financial Results for the Three Months Ended June 30, 2021, including $1,000,000+ of Sales from Viactiv® Products in the First Month of Guardion’s Ownership
August 16, 2021 08:15 ET | Guardion Health Sciences, Inc.
HOUSTON, Aug. 16, 2021 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a clinical nutrition and diagnostics company that develops clinically...
GuardionHealthSciences (002).jpg
Guardion Health Sciences to Exhibit at the American Society of Cataract and Refractive Surgery Annual Meeting
July 22, 2021 16:15 ET | Guardion Health Sciences, Inc.
SAN DIEGO, July 22, 2021 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a clinical nutrition and diagnostics company that develops clinically...
GuardionHealthSciences (002).jpg
Guardion Health Sciences to Be Added to the Russell 3000 Index
June 14, 2021 08:05 ET | Guardion Health Sciences, Inc.
SAN DIEGO, June 14, 2021 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a clinical nutrition and diagnostics company that develops clinically...
GuardionHealthSciences (002).jpg
Guardion Health Sciences Announces Appointment of Craig J. Sheehan as Chief Commercial Officer
June 03, 2021 08:17 ET | Guardion Health Sciences, Inc.
SAN DIEGO, June 03, 2021 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a clinical nutrition and diagnostics company that develops clinically...
GuardionHealthSciences (002).jpg
Guardion Health Sciences Broadens Clinical Nutrition Product Offerings by Closing Acquisition of Activ Nutritional, which owns the Science Backed, Revenue-Generating Viactiv® Product Line, from Adare Pharmaceuticals
June 02, 2021 09:07 ET | Guardion Health Sciences, Inc.
Acquisition to Transform and Strengthen Guardion’s Clinical Nutrition Product Portfolio Guardion Will Continue to Explore Additional Growth Opportunities to Further Expand its Presence in the...